AO
SNTI icon

Allen Operations’s Senti Biosciences Holdings SNTI Stock Holding History

Allen Operations’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,144
Closed -$5.92K – 35
2024
Q2 		$5.92K Hold
2,144
– – ﹤0.01% 33
2024
Q1 		$8.08K Hold
2,144
– – ﹤0.01% 33
2023
Q4 		$14.2K Hold
2,144
– – ﹤0.01% 33
2023
Q3 		$8.86K Hold
2,144
– – ﹤0.01% 39
2023
Q2 		$13.4K Hold
2,144
– – ﹤0.01% 37
2023
Q1 		$25.3K Hold
2,144
– – 0.01% 38
2022
Q4 		$30.2K Hold
2,144
– – 0.01% 40
2022
Q3 		$47K Hold
2,144
– – 0.01% 43
2022
Q2 		$42K Buy
+2,144
New +$172K 0.01% 41

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
8GI
8VC GP I Austin, Texas $39.6M AUM 36.39% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Allen Operations's SNTI Position: Q3 2024 in Review

Allen Operations sold out of Senti Biosciences Holdings (SNTI) in Q3 2024, closing a stake of 2,144 shares — an estimated $5.92K sold.

Allen Operations first reported a position in SNTI in Q2 2022 and held it in 9 quarters. The position peaked at $47K in Q3 2022. 14 funds tracked by Wall St. Rank hold SNTI as of Q3 2024.

  • Allen Operations reported no remaining Senti Biosciences Holdings position as of Q3 2024 after selling out during the quarter.
  • Allen Operations sold 2,144 Senti Biosciences Holdings shares in Q3 2024, an estimated $5.92K.
  • Allen Operations first reported a position in Senti Biosciences Holdings in Q2 2022 and held it in 9 quarters.
  • Allen Operations's Senti Biosciences Holdings position peaked at $47K in Q3 2022.
  • 14 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q3 2024.

Based on Allen Operations's 13F filing for Q3 2024, filed 7 Nov 2024.